Dr Reddy's Parkinson drug launched in the US
Advertisement
Dr Reddy's Laboratories has launched the generic drug Pramipexole dihydrochloride in the strength of 0.375 mg, 0.75 mg, 1.5 mg, 3 mg and 4.5 mg post approval from USFDA
Dr Reddy's Laboratories has recently announced the launch of its generic drug for Parkinson's treatment in the US market. The development is reported post approval from the US Food and Drug Administration received by the company.
Dr Reddy’s Labs have made available the generic drug- Pramipexole dihydrochloride extended release tablets in the 0.375 mg, 0.75 mg, 1.5 mg, 3 mg and 4.5 mg, as reported by the company to PTI.
The company's product is generic version of Mirapex ER tablets. "The Mirapex ER brand and generic had US sales of approximately USD 48.3 million MAT for the most recent twelve months ending in June 2015 according to IMS Health," it said.
The DRL product is available in bottle count sizes of 30, it added.
Dr Reddy's Laboratories has recently announced the launch of its generic drug for Parkinson's treatment in the US market. The development is reported post approval from the US Food and Drug Administration received by the company.
Dr Reddy’s Labs have made available the generic drug- Pramipexole dihydrochloride extended release tablets in the 0.375 mg, 0.75 mg, 1.5 mg, 3 mg and 4.5 mg, as reported by the company to PTI.
The company's product is generic version of Mirapex ER tablets. "The Mirapex ER brand and generic had US sales of approximately USD 48.3 million MAT for the most recent twelve months ending in June 2015 according to IMS Health," it said.
The DRL product is available in bottle count sizes of 30, it added.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.